Cargando…

A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research

For genomic medicine research to be fully translated into clinical care, it is critical for researchers to engage stakeholders who ultimately regulate the use of genomic technologies and therapeutics within healthcare practice. Herein, we describe an example of how this might work.

Detalles Bibliográficos
Autores principales: O’Daniel, Julianne M., Berg, Jonathan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031300/
https://www.ncbi.nlm.nih.gov/pubmed/27655359
http://dx.doi.org/10.1186/s13073-016-0351-7
_version_ 1782454782999396352
author O’Daniel, Julianne M.
Berg, Jonathan S.
author_facet O’Daniel, Julianne M.
Berg, Jonathan S.
author_sort O’Daniel, Julianne M.
collection PubMed
description For genomic medicine research to be fully translated into clinical care, it is critical for researchers to engage stakeholders who ultimately regulate the use of genomic technologies and therapeutics within healthcare practice. Herein, we describe an example of how this might work.
format Online
Article
Text
id pubmed-5031300
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50313002016-09-29 A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research O’Daniel, Julianne M. Berg, Jonathan S. Genome Med Comment For genomic medicine research to be fully translated into clinical care, it is critical for researchers to engage stakeholders who ultimately regulate the use of genomic technologies and therapeutics within healthcare practice. Herein, we describe an example of how this might work. BioMed Central 2016-09-21 /pmc/articles/PMC5031300/ /pubmed/27655359 http://dx.doi.org/10.1186/s13073-016-0351-7 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Comment
O’Daniel, Julianne M.
Berg, Jonathan S.
A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research
title A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research
title_full A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research
title_fullStr A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research
title_full_unstemmed A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research
title_short A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research
title_sort missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031300/
https://www.ncbi.nlm.nih.gov/pubmed/27655359
http://dx.doi.org/10.1186/s13073-016-0351-7
work_keys_str_mv AT odanieljuliannem amissinglinkinthebenchtobedsideparadigmengagingregulatorystakeholdersinclinicalgenomicsresearch
AT bergjonathans amissinglinkinthebenchtobedsideparadigmengagingregulatorystakeholdersinclinicalgenomicsresearch
AT odanieljuliannem missinglinkinthebenchtobedsideparadigmengagingregulatorystakeholdersinclinicalgenomicsresearch
AT bergjonathans missinglinkinthebenchtobedsideparadigmengagingregulatorystakeholdersinclinicalgenomicsresearch